Paradigm Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,800
Closed -$42.9K 432
2025
Q4
$42.9K Hold
1,800
0.01% 424
2025
Q3
$47.4K Hold
1,800
0.01% 398
2025
Q2
$51.4K Hold
1,800
0.01% 393
2025
Q1
$44.8K Hold
1,800
0.01% 413
2024
Q4
$40.8K Sell
1,800
-200
-10% -$4.34K 0.01% 415
2024
Q3
$42.6K Sell
2,000
-300
-13% -$5.91K 0.01% 414
2024
Q2
$43.9K Hold
2,300
0.01% 412
2024
Q1
$44.3K Hold
2,300
0.01% 435
2023
Q4
$47.9K Hold
2,300
0.01% 429
2023
Q3
$49.5K Buy
2,300
+1,700
+283% +$41.3K 0.01% 424
2023
Q2
$14.4K Hold
600
﹤0.01% 500
2023
Q1
$12.8K Hold
600
﹤0.01% 486
2022
Q4
$9.8K Hold
600
﹤0.01% 503
2022
Q3
$8.42K Buy
+600
New +$11.3K ﹤0.01% 471

Other funds holding FMS

Paradigm Asset Management's FMS Position: Q1 2026 in Review

Paradigm Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 1,800 shares — an estimated $42.9K sold.

Paradigm Asset Management first reported a position in FMS in Q3 2022 and held it in 14 quarters. The position peaked at $51.4K in Q2 2025. 220 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Paradigm Asset Management reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • Paradigm Asset Management sold 1,800 Fresenius Medical Care shares in Q1 2026, an estimated $42.9K.
  • Paradigm Asset Management first reported a position in Fresenius Medical Care in Q3 2022 and held it in 14 quarters.
  • Paradigm Asset Management's Fresenius Medical Care position peaked at $51.4K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.